CDTX vs MAR · rev $1.3M vs P/E 32, rev $26.19B
Cidara Therapeutics Inc (CDTX) versus Marriott International Inc (MAR) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Marriott International Inc (MAR) is a lodging company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported MAR revenue for 2025-12-31 was $26.19B. Net income was $2.60B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
CDTX currently screens at market cap $6.96B. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Not investment advice. Open the CDTX and MAR stock pages for the full models.
Not investment advice.